Vbi Vaccines Stock Probability of Future Stock Price Finishing Over 11.0

VBIV Stock  USD 0.63  0.02  3.28%   
VBI Vaccines' future price is the expected price of VBI Vaccines instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of VBI Vaccines performance during a given time horizon utilizing its historical volatility. Check out VBI Vaccines Backtesting, VBI Vaccines Valuation, VBI Vaccines Correlation, VBI Vaccines Hype Analysis, VBI Vaccines Volatility, VBI Vaccines History as well as VBI Vaccines Performance.
For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.
  
At this time, VBI Vaccines' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to climb to 1.04 in 2024, despite the fact that Price Earnings Ratio is likely to grow to (93.62). Please specify VBI Vaccines' target price for which you would like VBI Vaccines odds to be computed.

VBI Vaccines Target Price Odds to finish over 11.0

The tendency of VBI Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 11.00  or more in 90 days
 0.63 90 days 11.00 
close to zero percent
Based on a normal probability distribution, the odds of VBI Vaccines to move over $ 11.00  or more in 90 days from now is close to zero percent (This VBI Vaccines probability density function shows the probability of VBI Stock to fall within a particular range of prices over 90 days) . Probability of VBI Vaccines price to stay between its current price of $ 0.63  and $ 11.00  at the end of the 90-day period is about 43.29 .
Given the investment horizon of 90 days VBI Vaccines has a beta of 0.42. This entails as returns on the market go up, VBI Vaccines average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding VBI Vaccines will be expected to be much smaller as well. Additionally VBI Vaccines has an alpha of 0.2615, implying that it can generate a 0.26 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   VBI Vaccines Price Density   
       Price  

Predictive Modules for VBI Vaccines

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as VBI Vaccines. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of VBI Vaccines' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.030.647.41
Details
Intrinsic
Valuation
LowRealHigh
0.071.468.23
Details
Naive
Forecast
LowNextHigh
0.010.567.32
Details
1 Analysts
Consensus
LowTargetHigh
3.644.004.44
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as VBI Vaccines. Your research has to be compared to or analyzed against VBI Vaccines' peers to derive any actionable benefits. When done correctly, VBI Vaccines' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in VBI Vaccines.

VBI Vaccines Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. VBI Vaccines is not an exception. The market had few large corrections towards the VBI Vaccines' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold VBI Vaccines, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of VBI Vaccines within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
0.26
β
Beta against NYSE Composite0.42
σ
Overall volatility
0.06
Ir
Information ratio 0.03

VBI Vaccines Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of VBI Vaccines for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for VBI Vaccines can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
VBI Vaccines had very high historical volatility over the last 90 days
VBI Vaccines has some characteristics of a very speculative penny stock
VBI Vaccines has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 8.68 M. Net Loss for the year was (92.84 M) with loss before overhead, payroll, taxes, and interest of (10.19 M).
VBI Vaccines currently holds about 82.41 M in cash with (60.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32.
VBI Vaccines has a frail financial position based on the latest SEC disclosures
Latest headline from investorplace.com: VBIV Stock Earnings VBI Vaccines Beats EPS, Misses Revenue for Q4 2023

VBI Vaccines Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of VBI Stock often depends not only on the future outlook of the current and potential VBI Vaccines' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. VBI Vaccines' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding15.6 B
Cash And Short Term Investments23.7 M

VBI Vaccines Technical Analysis

VBI Vaccines' future price can be derived by breaking down and analyzing its technical indicators over time. VBI Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of VBI Vaccines. In general, you should focus on analyzing VBI Stock price patterns and their correlations with different microeconomic environments and drivers.

VBI Vaccines Predictive Forecast Models

VBI Vaccines' time-series forecasting models is one of many VBI Vaccines' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary VBI Vaccines' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about VBI Vaccines

Checking the ongoing alerts about VBI Vaccines for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for VBI Vaccines help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
VBI Vaccines had very high historical volatility over the last 90 days
VBI Vaccines has some characteristics of a very speculative penny stock
VBI Vaccines has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 8.68 M. Net Loss for the year was (92.84 M) with loss before overhead, payroll, taxes, and interest of (10.19 M).
VBI Vaccines currently holds about 82.41 M in cash with (60.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32.
VBI Vaccines has a frail financial position based on the latest SEC disclosures
Latest headline from investorplace.com: VBIV Stock Earnings VBI Vaccines Beats EPS, Misses Revenue for Q4 2023
When determining whether VBI Vaccines is a strong investment it is important to analyze VBI Vaccines' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact VBI Vaccines' future performance. For an informed investment choice regarding VBI Stock, refer to the following important reports:
Check out VBI Vaccines Backtesting, VBI Vaccines Valuation, VBI Vaccines Correlation, VBI Vaccines Hype Analysis, VBI Vaccines Volatility, VBI Vaccines History as well as VBI Vaccines Performance.
For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for VBI Stock analysis

When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Commodity Directory
Find actively traded commodities issued by global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(9.79)
Revenue Per Share
0.689
Quarterly Revenue Growth
19.896
Return On Assets
(0.29)
Return On Equity
(2.20)
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.